Search research articles
Contact Us
Filters
Showing results (621-630 of 763) with videos related to
Page
of 77
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2018
Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas
Dusten Unruh, Snezana Mirkov, Brian Wray, et al.
Oncoimmunology
|
April 18, 2022
Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system
Jun Wei, Renduo Song, Aria Sabbagh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2012
Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy
Emmanuelle Huillard, Rintaro Hashizume, Joanna J Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2022
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models
Fuyang Li, Kathryn M Bondra, Samson Ghilu, et al.
Neuro-Oncology
|
December 6, 2013
Targeting Wee1 for the treatment of pediatric high-grade gliomas
Sabine Mueller, Rintaro Hashizume, Xiaodong Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2021
Neural stem cells secreting bispecific T cell engager to induce selective antiglioma activity
Katarzyna C Pituch, Markella Zannikou, Liliana Ilut, et al.
Liver Cancer
|
December 14, 2017
Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study
Clarence Yen, Rohini Sharma, Lorenza Rimassa, et al.
Journal of Neuro-Oncology
|
November 18, 2008
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
Gaspar J Kitange, Brett L Carlson, Ann C Mladek, et al.
Frontiers in Oncology
|
December 12, 2022
Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer
David Howard, David James, Jezabel Garcia-Parra, et al.
Oncotarget
|
October 8, 2016
Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model
Stefan Grossauer, Katharina Koeck, Nicole E Murphy, et al.
Page
of 77
Search research articles
Search
Showing results (621-630 of 763) with videos related to
Sort By:
Page
of 77
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2018
Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas
Dusten Unruh, Snezana Mirkov, Brian Wray, et al.
Oncoimmunology
|
April 18, 2022
Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system
Jun Wei, Renduo Song, Aria Sabbagh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2012
Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy
Emmanuelle Huillard, Rintaro Hashizume, Joanna J Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2022
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models
Fuyang Li, Kathryn M Bondra, Samson Ghilu, et al.
Neuro-Oncology
|
December 6, 2013
Targeting Wee1 for the treatment of pediatric high-grade gliomas
Sabine Mueller, Rintaro Hashizume, Xiaodong Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2021
Neural stem cells secreting bispecific T cell engager to induce selective antiglioma activity
Katarzyna C Pituch, Markella Zannikou, Liliana Ilut, et al.
Liver Cancer
|
December 14, 2017
Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study
Clarence Yen, Rohini Sharma, Lorenza Rimassa, et al.
Journal of Neuro-Oncology
|
November 18, 2008
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
Gaspar J Kitange, Brett L Carlson, Ann C Mladek, et al.
Frontiers in Oncology
|
December 12, 2022
Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer
David Howard, David James, Jezabel Garcia-Parra, et al.
Oncotarget
|
October 8, 2016
Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model
Stefan Grossauer, Katharina Koeck, Nicole E Murphy, et al.
Page
of 77